Dechra Pharmaceuticals (LON:DPH) has acquired Florida-based veterinary dermatological business DermaPet as part of its effort to become a leading supplier... This website uses cookies. We use cookies ...

Britain's Dechra Pharmaceuticals <DECP.L> said on Friday it had agreed to buy Florida-based DermaPet Inc for up to $64 million to increase its presence in the U.S market for pet shampoos ...

Overland Park-based Dechra Veterinary Products has completed a $42 million acquisition of DermaPet, a veterinary dermatology company based in Florida. The Business Journals Select a City ...

The Company announces that, pursuant to the terms of the DermaPet Purchase Acquisition Agreement dated 22 October 2010 (the "Agreement"), a payment in the sum of US$15 million (£9.4 million) has ...

Gross assets at 30 June 2010 were £1.75m ($2.8m). In the last full financial year ended 31 December 2009, DermaPet achieved revenue of £6.68m ($10.7m) and pre-tax income of £2.5m ($4m).

PET drugs firm Dechra Pharmaceuticals yesterday reported an increase in revenues, boosted by the acquisition of two companies at the tail-end of last year.

The company has obtained critical mass in the US with the acquisition of DermaPet in October 2010, and management envisage a number of regulatory approvals by the US Food and Drug Administration ...